In April 2022, the Therapeutic Goods Administration (TGA) reported a shortage of semaglutide in Australia in the setting of a worldwide shortage of semaglutide due to an unexpected increase in demand
Conclusions Following the initiation of semaglutide, other GLP-1 agonists, or GLP-1/GIP dual agonists, practitioners should be aware of the potential severe complications, such as colonic ischemia, and properly educate their patients about these risks
Body Contouring Technologies Body sculpting treatments use various technologies to reduce fat and tighten skin without surgery
Combined with plasma donation's inherent 500-800mL blood volume loss, this requires individual risk assessment
This can include fewer days with stomach pain and reduced frequency of urgent bowel movements
They work with adults using Tirzepatide or Mounjaro offering clear plans, education, and careful adjustments through every dose phase to ensure steady progress